ArticleCNS neuroscience & therapeutics2019
Pregabalin: A range of misuse-related unanswered questions.
Article in CNS neuroscience & therapeutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- A case report of pregabalin misuse leading to drug dependence.Frontiers in psychiatry · 2025Article
- A Hidden Pandemic? Abuse of Gabapentinoids: A Brief Review of Recent Studies.Current drug research reviews · 2025Review
- Adverse Drug Reactions to Opioids: A Study in a National Pharmacovigilance Database.Drug safety · 2023Article
- Misuse of Pregabalin: a qualitative study from a patient's perspective.BMC public health · 2023Article
- Pregabalin Use/Misuse: A Source of Consternation in Western Punjab.Indian journal of psychological medicine · 2023Article
- Beyond the 'purple drank': Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports.Journal of psychopharmacology (Oxford, England) · 2021Article
- Availability of Illegal Drugs During the COVID-19 Pandemic in Western Germany.Frontiers in psychiatry · 2021Article
- Current Evidence on Abuse and Misuse of Gabapentinoids.Drug safety · 2020Review
- Exploring the Baseline Knowledge and Experience of Healthcare Professionals in the United Kingdom on Novel Psychoactive Substances.Brain sciences · 2020Article
- Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options.Frontiers in psychiatry · 2020Review
- Pregabalin: A range of misuse-related unanswered questions.CNS neuroscience & therapeutics · 2019Article
- Pregabalin Abuse in Combination With Other Drugs: Monitoring Among Methadone Patients.Frontiers in psychiatry · 2019Article
- Preliminary Evidence of Pregabalin Misuse among Prescription and/or Illicit Opioid (Mis)users.Journal of psychoactive drugsArticle
- Managing Pregabalin Misuse in Clinical Practice: A Growing Concern in Pain, Palliative and Anaesthesia Care.Indian journal of palliative careArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.